Vv1

Other

Description

Vv1 is not a recognized drug name in current oncology literature, clinical databases, or CRC treatment guidelines. It does not correspond to any known approved, investigational, or experimental agent used in colorectal cancer therapy. If this is an internal code name, a typographical error, or a novel compound in early preclinical development, clinical information cannot be accurately provided without validated source data.

Mechanism of Action

Mechanism of action is unknown. No credible pharmacological data for a compound designated 'Vv1' exists in peer-reviewed literature, FDA/EMA registries, or ClinicalTrials.gov as of the current knowledge cutoff.

Side Effects

Unknown – no clinical safety data available

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04291105 Phase 2
Active, not recruiting
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
United States, Brazil